ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000262412.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.034790152	Resistant
ENSG00000262412.1	ABT-263 (navitoclax)	Esophageal cancer	0.019998254	Sensitive